Block GA - Search Results

1

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

Block GA, Port FK. Block GA, et al. Am J Kidney Dis. 2000 Jun;35(6):1226-37. doi: 10.1016/s0272-6386(00)70064-3. Am J Kidney Dis. 2000. PMID: 10845841 Review.

2

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Block GA, et al. Am J Kidney Dis. 1998 Apr;31(4):607-17. doi: 10.1053/ajkd.1998.v31.pm9531176. Am J Kidney Dis. 1998. PMID: 9531176

3

Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients.

Block GA. Block GA. Clin Nephrol. 2000 Oct;54(4):318-24. Clin Nephrol. 2000. PMID: 11076108 Review.

4

Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis).

Block GA. Block GA. Curr Opin Nephrol Hypertens. 2001 Nov;10(6):741-7. doi: 10.1097/00041552-200111000-00003. Curr Opin Nephrol Hypertens. 2001. PMID: 11706300 Review.

5

The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease.

Block GA. Block GA. Kidney Int Suppl. 2003 Nov;(87):S131-6. doi: 10.1046/j.1523-1755.64.s87.20.x. Kidney Int Suppl. 2003. PMID: 14531786 Free article. Review.

6

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG. Block GA, et al. N Engl J Med. 2004 Apr 8;350(15):1516-25. doi: 10.1056/NEJMoa031633. N Engl J Med. 2004. PMID: 15071126 Free article. Clinical Trial.

7

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Block GA, et al. J Am Soc Nephrol. 2004 Aug;15(8):2208-18. doi: 10.1097/01.ASN.0000133041.27682.A2. J Am Soc Nephrol. 2004. PMID: 15284307

8

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P. Block GA, et al. Kidney Int. 2005 Oct;68(4):1815-24. doi: 10.1111/j.1523-1755.2005.00600.x. Kidney Int. 2005. PMID: 16164659 Free article. Clinical Trial.

9

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.

Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Block GA, et al. Kidney Int. 2007 Mar;71(5):438-41. doi: 10.1038/sj.ki.5002059. Epub 2007 Jan 3. Kidney Int. 2007. PMID: 17200680 Free article. Clinical Trial.

10

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.

Block GA, Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA; TARGET Investigators. Block GA, et al. Nephrol Dial Transplant. 2008 Jul;23(7):2311-8. doi: 10.1093/ndt/gfn026. Epub 2008 Feb 29. Nephrol Dial Transplant. 2008. PMID: 18310602 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters